Atlas Trials

Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT07135804 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07135804
Sponsor
Second Affiliated Hospital of Nanchang University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Nasopharyngeal Squamous Cell Carcinoma
Start date
2025-09-01
Primary completion
2028-04-30
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.